Screener
Pacific Biosciences of California PACB Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $61.8M.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's total debt?
- Pacific Biosciences of California (PACB) reported total debt of $61.8M in Q2 2026.
- How has Pacific Biosciences of California's total debt changed year-over-year?
- Pacific Biosciences of California's total debt increased by 17.1% year-over-year, from $52.79M to $61.8M.
- What is the long-term trend for Pacific Biosciences of California's total debt?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's total debt has grown at a 6.3% compound annual growth rate (CAGR), from $42M to $57.04M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Pacific Biosciences of California's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude